Search Within

Martin Henner Voss

  1. "Body Imaging Service"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (20)
  3. Research Letter (1)
Groups
  1. Body Imaging Service (42)
  2. Department of Medicine (42)
  3. Genitourinary Oncology Service (42)
  4. Radiology, Department of (42)
  5. Solid Tumor Oncology Division (42)
  6. Weinberg Fellows (30)

More Groups

People
  1. Robert Motzer (37)
  2. Darren Feldman (30)
  3. Chung-Han Lee (29)
  4. Maria Carlo (23)
  5. Ritesh Kotecha (20)
  6. Joshua Chaim (17)

More People

Years
  1. 2024 (4)
  2. 2023 (5)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. European Urology (3)
  3. Cancer (2)
  4. Cancer Research (2)
  5. Clinical Cancer Research (2)
  6. Clinical Genitourinary Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (4)
  3. Elsevier Inc. (3)
  4. Elsevier Science, Inc. (3)
  5. Oxford University Press (3)
  6. Wiley Blackwell (3)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Progression-free survival after second line of therapy (PFS-2) for metastatic clear cell renal cell carcinoma (ccRCC) in patients treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Deciphering radiological stable disease to immune checkpoint inhibitors
    Journal Article

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Callahan, M. K.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy
    Journal Article

    Carlo, M. I.; Attalla, K.; Mazaheri, Y.; Gupta, S.; Yildirim, O.; Murray, S. J.; Coskey, D. T.; Kotecha, R.; Lee, C. H.; Feldman, D. R.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • An evaluation of the role of tumor load in cytoreductive nephrectomy
    Journal Article

    Silagy, A. W.; Duzgol, C.; Marcon, J.; DiNatale, R. G.; Mano, R.; Blum, K. A.; Reznik, E.; Voss, M. H.; Motzer, R. J.; Coleman, J. A.; more...
    CUAJ-Canadian Urological Association Journal (2020)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
    Journal Article

    Ged, Y.; Gupta, R.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    BMC Urology (2020)

    Fulltext@MSK | Save
  • The spinal distribution of metastatic renal cell carcinoma: Support for locoregional rather than arterial hematogenous mode of early bony dissemination
    Meeting Abstract

    Attalla, K.; Duzgol, C.; McLaughlin, L.; Flynn, J.; Ostrovnaya, I.; DiNatale, R. G.; Silagy, A. W.; Coleman, J.; Lee, C. H.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save